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Background: Glomerular filtration rate (GFR) is the best index of renal function, but age, gender and ethnicity can
putatively affect its values. The aim of this study was to establish reference values for GFR in healthy Brazilian
subjects while taking these factors into account.
Methods: In this cross-sectional study, GFR was measured by the 51Cr-EDTA single-injection method. GFR reference
values were developed according to CLSI Guidelines for Defining, Establishing, and Verifying Reference Intervals in
the Clinical Laboratory (CLSI C28 protocol).
Results: The age range of the 285 healthy individuals was 19 to 70 years, 57% were females, and GFR was 106 ±
18 mL/min/1.73 m2. There was no difference between male and female GFRs (108 ± 18 vs. 104 ± 18 mL/min/1.73 m2
respectively, P = 0.134), and reference values were therefore developed from the pooled sample. GFR values were
lower in subjects aged ≥45 years as compared with those younger than 45 years (98 ± 15 vs.112 ± 18 mL/min/1.73 m2,
P < 0.001). Based on mean ± 2 SD, GFR reference values were 76 to 148 mL/min/1.73 m2 for subjects younger than
45 years and 68 to 128 mL/min/1.73 m2 for individuals older than 45 years, irrespective of gender.
Conclusion: The age-adjusted reference intervals reported may be reliably adopted to evaluate kidney function, since
they are based on recommended standards.
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The National Kidney Foundation (NKF) recommends esti-
mating glomerular filtration rate (GFR) with creatinine-
based equations, such as the Modification of Diet in Renal
Disease (MDRD) study equation or the recently developed,
and more accurate, Chronic Kidney Disease Epidemiology
(CKD-EPI) collaboration group equation (www.kidney.org,
retrieved January 2013) [1-4]. However, some clinical
situations require a more precise evaluation of GFR, such
as before kidney transplantation, extremes of age and body
size, severe malnutrition or obesity, diseases of the skeletal
muscle, paraplegia or quadriplegia, vegetarian diet, and be-
fore administration of prolonged courses of toxic
medications [5,6]. In this scenario, GFR should ideally be* Correspondence: silveirosandra@gmail.com
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reproduction in any medium, provided the ormeasured by conventional clearance methods, such as inu-
lin, iohexol, iothalamate, or 51Cr-EDTA clearance.
GFR decline with aging is a well-known phenomenon,
and reference values should take it into account [7,8].
However, some studies have suggested that GFR may
also be affected by sex, with women exhibiting either
higher [9], lower [7] or similar [10] GFR values as
compared to men. An even more controversial issue,
which remains unsettled, is the potential influence of
ethnicity on GFR. Therefore, the aim of this study was
to establish reference range values for GFR in healthy
Brazilian individuals while taking these factors into
account.Methods
Study participants
This cross-sectional study was conducted in healthy
Southern Brazilian volunteers recruited from the com-
munity and hospital staff. Two hundred and eighty-fiveLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.




Age (years) 41 ± 13
Skin color (white/black)* 266/19
Body mass index (kg/m2) 25 ± 3 (16–34)
Body surface area (m2) 1.80 ± 0.19 (1.32-2.33)
Data expressed as mean ± SD (range) or number of cases.
*Self-reported.
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health status was checked by a medical interview, a
complete physical examination, and basic laboratory tests
(fasting plasma glucose, lipids, liver function tests and urin-
alysis). Exclusion criteria were the presence of kidney disease
(as detected by urinary albumin excretion >30 mg/g creatin-
ine in a spot urine sample and sediment analysis), impaired
glucose tolerance (fasting plasma glucose >100 mg/dL), ar-
terial hypertension (blood pressure levels higher than
140/90 mmHg), cardiovascular disease (history and
previous medical records) or presence of any other ac-
tive disease, body mass index (BMI) >35 kg/m2, history
of cancer in the last 5 years and use of drugs (except
for oral contraceptives and thyroid hormones).
Subjects were classified as white, black, or other as
self-reported, pursuant to current recommendations.
The body weight and height of subjects (not wearing
shoes or coats) were measured using an anthropometric
scale, with measurements recorded to the nearest 100 g
for weight and the nearest 0.1 cm for height. BMI was
calculated using the formula kg/m2. Blood pressure was
measured in the sitting position after a 5-min rest.
Laboratory measurements
Procedure for GFR measurement
GFR was measured by the 51Cr-EDTA single-injection
method, and the procedure is described below [11]. 1)
Patient preparation: caffeine drinks and exercise were
avoided. A low-protein meal and adequate hydration
during the test were prescribed. Body surface area (BSA)
was calculated according to the Gehan and George for-
mula: 0.0235 × ([100 × height]0.42246) × (weight0.51456)
[12]. 2) Syringe preparation: a 5.55 MBq dose of 51Cr-
EDTA was measured by volume, and the syringe was
filled completely up to the tip of the needle. 3) Injection
technique: the entire dose was injected into the blood-
stream without extravasation. 4) Blood sampling: samples
were collected from the contralateral arm, 2, 3 and 4 h
post-injection. The specimens were centrifuged at 1000 g
for 10 min and 2 mL of plasma were pipetted into
counting tubes in duplicate. 5) Preparation of the stand-
ard: a predetermined volume of tracer (2 mL) was drawn
up using a pipette, and the activity was emptied into
the volumetric flask filled with water to the mark. 6)
Counting: plasma samples were counted using appro-
priate standards and blanks for background in a well
counter. 7) GFR calculation: the logarithm of the
plasma activity was plotted as a function of time and
the apparent zero-time plasma activity determined by
extrapolation of the linear part of the curve. A con-
stant correction factor of 0.87 was used for the missing
AUC due to the fast exponential; therefore, the GFR
was calculated as volume of distribution x 0.693 x
0.87 × 1000/t1/2 (according to Chantler), and expressedas mL/min/1.73 m2 [13]. The mean intra-individual
coefficient of variation of GFR at our laboratory is
12% [7].
Fasting plasma glucose was measured by the glucose oxi-
dase method, and albuminuria, by immunoturbidimetry.
Statistical analysis
Results were expressed as mean ± standard deviation or
median (range or interquartile range), unless otherwise
stated. The Kolmogorov–Smirnov (K-S) test was employed
to assess the distribution of variables, and reference values
were defined as mean ± 2 standard deviations. The mini-
mum number of subjects to be included in each partition
was 120, based on the recommendations of Clinical and
Laboratory Standards Institute (CLSI) C28 protocol for de-
termining reference intervals [14]. Reed’s criterion was
used to identify outliers, as recommended by Fraser [15],
as were stem-and-leaf plots and histograms. Correlation
between variables was evaluated by Pearson’s correlation
test. The unpaired Student’s t-test and chi-square tests
were used as appropriate. Simple and multivariate regres-
sion analyses were employed to evaluate the influence of
age and gender on GFR (dependent variable). The statis-
tical package used was PASW Statistics 19, and the level of
significance adopted was 5%.
Ethics
The Hospital de Clínicas de Porto Alegre Research Eth-
ics Committee approved the study protocol, and all
subjects provided written informed consent.
Results
Two hundred and eighty-five healthy adults, 162 (57%)
women, 266 (93%) white, 19 (7%) black, aged 41 ± 13 -
years (range, 19–70 years), BMI 25 ± 3 kg/m2, were
evaluated (Table 1). Overall, the GFR measured by 51Cr-
EDTA clearance (51Cr-GFR) was 106 ± 18 mL/min/
1.73 m2 (range, 67 to 153 mL/min/1.73 m2), with a
Gaussian distribution.
There was a significant inverse correlation between age
and GFR (r = −0.33, P <0.001). Simple linear regression
analysis confirmed the influence of age on GFR (r2 = 0.11,
P <0.001). After stratifying data by age decades, we found
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age (Figure 1). We compared the slope of the GFR regres-
sion equation (y = a + bx) in subjects younger than 45
(GFR = 103.4 + 0.26 x age) vs. older than 45 years of age
(GFR = 136.4 – 0.72 x age). The slope of younger subjects
was not different from zero (one sample t test, P = 0.169),
whereas the slope of the older group was consistent with a
significant decrease in GFR (P = 0.003). Reference GFR
values (mean ± 2 SD) were calculated, ranging from 76 to
148 mL/min/1.73 m2 for individuals aged <45 years and
68 to 128 mL/min/1.73 m2 for subjects older than 45 years.
These values are depicted in Figure 2.
To assess the potential relation between GFR and gen-
der, the 123 male subjects were compared to the 162 fe-
male participants. Men and women were matched by
age (40 ± 14 vs. 41 ± 13 years, P = 0.66); BMI (25 ± 3 vs.
25 ± 4 kg/m2, P = 0.13), and ethnicity (93% vs. 94% white,
P = 0.81), respectively. As expected, BSA was greater in
men (1.9 ± 0.16 vs. 1.7 ± 0.15 m2, P < 0.001). After adjusting
for BSA, the mean GFR was similar in men and women
(108 ± 18 vs.104 ± 18 mL/min/1.73 m2 respectively,
P = 0.13). The inverse correlation observed between
GFR and age was similar for men and women (r = −0.45
and −0.33 respectively, P = 0.243). Simple linear regression
analysis confirmed that gender did not influence GFR
(r2 = −0.002; P = 0.47). Accordingly, multiple linear re-
gression was performed with GFR as the dependent
variable, and age and gender simultaneously as inde-
pendent variables, yielding an r2 of 0.15, P < 0.001 for
age only. On comparison between the 93 women and
72 men aged <45 years, there was no significant differ-
ence between GFRs (111 ± 18 vs. 113 ± 18 respectively,
P = 0.51). Comparison between the 69 women and 51
men aged >45 years, however, showed a trend towardFigure 1 Glomerular filtration rate (GFR) values presented as mean (con
line) by age range. Panel A: ages 20–45 years, regression: GFR = 103.4 + 0.26 xlower GFRs in the female group (96 ± 14 vs. 101 ± 16,
P = 0.08).
To analyze the influence of skin color on GFR, we
compared the 19 black individuals with the 266 white
subjects. These groups were similar regarding age (38 ±
10 vs 41 ± 14 years respectively, P = 0.375), but GFR was
higher in the black subjects (116 ± 19 vs 105 ± 18 mL/
min/1.73 m2, P = 0.01), as was BMI (28 ± 3 vs 24 ± 3 kg/
m2, P < 0.001). However, final GFR results were similar
when analyzed with (106 mL/min/1.73 m²) or without
(105 mL/min/1.73 m²) the black subjects.
The influence of BMI on GFR was also evaluated.
Twenty-one of the 285 subjects had a BMI ≥30 kg/m2.
The adjusted BSA-GFR was similar in obese and non-
obese subjects (106±18 vs. 106±18 mL/min/1.73 m2 re-
spectively, P = 0.951). Conversely, non-adjusted GFR was
significantly higher in obese subjects (123±24 vs. 109±22
mL/min respectively, P = 0.006). Likewise, there was a sig-
nificant positive correlation between BMI and unadjusted-
BSA GFR (r = 0.29, P <0.001), but no correlation between
BMI and adjusted GFR (r = −0.05, P = 0.359).
Discussion
The present study confirms that age must be taken into
account when establishing GFR reference values, since a
decline in kidney function with age is a well-known
phenomenon [10,16-18]. For the 20-to-45-year age group,
GFR (mean ± 2 SD) ranged from 76 to 148 mL/min/
1.73 m2, without distinction between men and women,
versus 68 to 128 mL/min/1.73 m2 in subjects older than
45 years, with a trend toward lower GFRs in older women.
Compared to previous studies, our data showed slightly
higher GFRs for younger individuals, probably because
the participants of these studies were potential kidney
donors [8-10,16,17], whereas the volunteers in our studytinuous line) ± 2SD (dashed lines) and GFR regression equation (bold
age; Panel B: ages 45–70 years, regression: GFR = 136.4 – 0.72 x age.
Figure 2 Individual glomerular filtration rate (GFR) values, expressed as mean ± 2SD (dashed lines), in healthy individuals aged
<45 years vs. ≥45 years.
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tends to minimize selection bias, since donors are mostly
relatives of kidney recipients and may have a greater pro-
portion of unrecognized renal disease [17]. Therefore,
the results of the current study, which used a sample
composed entirely of healthy individuals, are suitable
to provide reference values.
Studies conducted several decades ago have clearly
established that GFR declines with ageing. However, the
vast majority of these studies were carried out on kidney
donors. The seminal studies from the 1950s demonstrated
that GFR decreases linearly with aging, with an increase in
the rate of decline after the age of 50 years [10,18].
Granerus and Aurell [10] compiled the datasets of eight
studies from the 1950s to 1980s and described a GFR de-
cline of up to 4 mL/min/decade for ages <50 years and of
10 mL/min/decade for ages above this cutoff value. This
pattern was confirmed by Slack and Wilson [19]. More re-
cently, Poggio et al. [9] found that GFR declines at a rate
of approximately 4 mL/min/decade in subjects younger
than 45 years of age, similar to what has been previously
reported. Grewal and Blake [16] report that GFR remains
constant until the age of 40 years and then starts to de-
cline; this is consistent with our results, which showed no
GFR decline before the age of 45 years but a noticeable
decrease in older subjects. This decrease is related to the
normal physiological process of organ senescence and is
associated with structural changes in the kidneys [20]. The
mean number of nephrons in adults is around 900,000,ranging from 200,000 to 2,000,000 [21]. Studies of living
kidney donors have shown that older donors exhibit a 30-
45% reduction in the number of functioning glomeruli
and a significantly lower GFR before donation as
compared with their younger counterparts [22]. A remark-
able study evaluated the renal function of 1203 living kid-
ney donors and demonstrated that, although up to 70% of
subjects over the age of 70 years had nephrosclerosis, the
decline in kidney function with aging was not fully
explained by this finding [8]. Further studies are still
required to assess whether these age-related histologic ab-
normalities are predictive of adverse outcomes.
In our study, we found no significant difference in GFR
values between men and women. Some studies corrobor-
ate this similarity [8,10,16,17]. A recent study reported
higher GFR values for men, but the difference did not hold
when GFR was normalized for BSA [8]. This is consistent
with our findings, as we reported 51Cr-GFR corrected for
BSA and no gender differences in GFR were demons-
trated. A previous analysis of a small sample of healthy
subjects described GFR values around 8% higher in men
than in women, especially after the age of 30 years, but
this difference disappeared when each age range was
analyzed individually [7]. Only one study reported higher
GFR values in women (3% higher as compared with men),
but the authors maintain that this difference is unlikely to
be clinically relevant [9]. Therefore, the vast majority of
the studies reveals no difference between male and female
GFR reference values. Our results suggest a trend toward
Soares et al. BMC Nephrology 2013, 14:54 Page 5 of 6
http://www.biomedcentral.com/1471-2369/14/54lower GFRs in older women. A very recent study of 1878
healthy potential donors described interesting new
findings, such as higher GFR/ECV (extracellular volume)
values in women, reinforcing the notion that GFR should
be corrected for ECV [23]. Expressing renal function as
the GFR/ECV (mL/min/L) has a direct physiological inter-
pretation, and can be an important adjunct to the usual
adjustment of GFR for BSA [24].
Another aspect that has been questioned is the rate of
age-related decline in renal function in men and women.
Some authors have described a faster rate of GFR decrease
in males [25]. Berg, analyzing a group of young (age 20–
50 years) Swedish potential kidney donors, found a signifi-
cant GFR decline only in men, ascribing a protective role
to estrogens in pre-menopausal women [26], but this
seems to be an isolated finding. In contrast, Ma et al. [27]
reported a more marked decline in GFR values with age in
Chinese women, but this also seems to constitute an aty-
pical phenomenon. The majority of studies have failed to
confirm any gender differences in age-related GFR decline
[10,16,28], which is consistent with our findings.
The influence of ethnicity on GFR values has been
assessed by some research groups. A Chinese study
described lower GFR reference values [27] as compared
with those of healthy Western populations [17], but higher
than those reported for Indian adults [29]. These
differences might be explained by peculiarities in dietary
intake among distinct populations, by differences in GFR
measurement methods, or, perhaps, by ethnicity itself.
Therefore, due to this possible variation, the development
of reference values of GFR for each specific population is
important. To the best of our knowledge, ours is the first
paper to report guideline-based GFR reference values for
Brazilian individuals. It bears mentioning that the Brazil-
ian population itself is composed of a massive “mix” of
different ethnic groups. Indeed, subjects who declare
themselves “white” actually represent different degrees
of miscegenation between several black and white
ethnicities, and the same applies to the subjects who
report their skin color as “black”. Therefore, we chose
not to stratify subjects by skin color for final analysis,
since GFR values were not different when the black
subjects were removed from the sample. Even though
GFR was higher among black subjects, body weight
was also greater in this group, which could represent a
confounding factor, as obesity has been associated with
hyperfiltration [30]. Furthermore, the number of self-
reported black subjects was very small (n = 19). The
potential role of ethnicity in GFR values still warrants
further investigation.
Regarding the influence of elevated BMI on GFR, we
found that the crude GFR (unadjusted for BSA) was sig-
nificantly higher in obese subjects. As the current
NKDEP recommendation is that measured GFR shouldbe adjusted for BSA (to address symmorphosis in kidney
function), we chose to merge the final results of obese
and non-obese subjects, but also presented the results of
each group of BMI separately [31]. It has been noted that
indexing GFR for BSA has limited effects on GFR results
in a population of “normal” body size, although the
consequences of adjustment can be substantial in
extremes of body weight [32]. The absence of associations
between BMI categories and BSA-adjusted GFR in our
and other studies raises questions regarding the appro-
priateness of indexing GFR for BSA in overweight
populations. In fact, recent papers have demonstrated that
obesity is associated with increased GFR, ERPF, and filtra-
tion fraction in non-diabetic individuals [4,30,33,34].
We chose to use the Gehan and George formula for BSA
estimation, since the Pearson correlation coefficient be-
tween this equation and the guideline-recommended
Haycock equation was r = 1.0 (P <0.001), with excellent
Bland-Altman agreement between the two formulae.
This is consistent with previous studies in which the per-
formance of these two equations was very similar. Con-
versely, in obese patients, the DuBois and DuBois equation
underestimated BSA by 3% in males and 5% in females [34].
When measuring GFR from 51Cr-EDTA clearance
through slope-intercept techniques, sampling is restricted
to the second phase of clearance, and systematic errors
introduced into the GFR values thus derived must be
corrected. Most commonly, correction of the slope-
intercept value for the approximation has been done
through use of the Bröchner-Mortensen [35] or Chantler
[13] equations. The linear Chantler equation uses a con-
stant multiplicative correction factor to adjust GFR values,
whereas the Bröchner-Mortensen equation uses a quad-
ratic correction and is dependent on the subject’s BSA
[11]. Fleming has compared the two equations and
pointed out their limitations: the Bröchner-Mortensen
equation underestimated GFR at higher values, with a
10% underestimation at 180 mL/min/1.73 m2, while the
Chantler equation gave a systematic overestimate of GFR,
with the error increasing with GFR, for a 30% overesti-
mate at 180 mL/min/1.73 m2 [36]. In short, the difference
between the two equations is negligible and the Chantler
correction can be used accurately.
One strength of the present study was the sample
composed entirely of healthy individuals. This stands in
contrast to the majority of previous studies, which mostly
included potential kidney donors, who are often related by
blood to patients with chronic kidney disease. Further-
more, our methods strictly followed the recommendations
of the CLSI Guidelines for determining reference intervals.
Conclusion
We conclude that age, but not sex, must be taken into
account in the determination of reference values for
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intervals reported in the present study may be reliably
adopted to evaluate kidney function.
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